Universidad de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2019

  1. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study

    Alzheimer's Research and Therapy, Vol. 11, Núm. 1

2015

  1. Recomendaciones para la utilización de biomarcadores de imagen PET en el proceso diagnóstico de las enfermedades neurodegenerativas que cursan con demencia: Documento de consenso SEMNIM y SEN

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 5, pp. 303-313

2013

  1. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

  2. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease

    Journal of Neural Transmission, Vol. 120, Núm. 5, pp. 807-812

2012

  1. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease

    European Journal of Neurology, Vol. 19, Núm. 8, pp. 1100-1107

2010

  1. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia

    Journal of Alzheimer's Disease, Vol. 22, Núm. 4, pp. 1065-1071

2000

  1. Estrógenos y enfermedad de Alzheimer: Bases, promesas y realidades

    Medicina Clinica, Vol. 114, Núm. 19, pp. 747-755

1998

  1. The effect of age and educational level in the Mini-Mental-State Examination scores. Normalised data from the population older than 70 in Pamplona, Spain

    Neurologia, Vol. 13, Núm. 3, pp. 111-119